Back
Mitek Systems, Inc. Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison
Sell
48
MITK
Mitek Systems, Inc.
Last Price:
$10.02
Seasonality Move:
19.16%
Sell
49
RARE
Ultragenyx Pharmaceutical, Inc.
Last Price:
$36.24
Seasonality Move:
6.21%
Sell
48
Mitek Systems, Inc. (MITK)
is a Sell
Is Mitek Systems, Inc. a Buy, Sell or Hold?
-
The current Mitek Systems, Inc. [MITK] share price is $9.24. The Score for MITK is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
MITK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Ultragenyx Pharmaceutical, Inc. (RARE)
is a Sell
Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?
-
The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $36.20. The Score for RARE is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MITK Stock Price Chart
What is Mitek Systems, Inc.'s stock price today?
-
The Mitek Systems, Inc. share price today is $9.24Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MITK is experiencing selling pressure, which indicates risk of future bearish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical, Inc.'s stock price today?
-
The Ultragenyx Pharmaceutical, Inc. share price today is $36.20Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight selling pressure.
MITK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 53.74 | Buy |
| Chaikin Money Flow: | -2114607 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.99 | Buy |
| Relative Strength Index (14 RSI): | 61.03 | Buy |
| Chaikin Money Flow: | -408394 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
MITK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.21 | Buy |
| 20-day SMA: | 9 | Buy |
| 50-day SMA: | 9.2 | Buy |
| 200-day SMA: | 9.31 | Sell |
| 8-day EMA: | 9.17 | Buy |
| 20-day EMA: | 9.12 | Buy |
| 50-day EMA: | 9.24 | Sell |
| 200-day EMA: | 9.51 | Sell |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.97 | Buy |
| 20-day SMA: | 34.2 | Buy |
| 50-day SMA: | 33.3 | Buy |
| 200-day SMA: | 33.78 | Buy |
| 8-day EMA: | 35.77 | Buy |
| 20-day EMA: | 34.71 | Buy |
| 50-day EMA: | 33.43 | Buy |
| 200-day EMA: | 34.79 | Buy |
Mitek Systems, Inc. Earnings Growth & MITK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.09 per share.
Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.
Mitek Systems, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||